EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update

Evangelia Maria Tsapakis iD, Michael Treiber, Calypso Mitkani iD, Zoe Drakaki, Anastasios Cholevas, Cleanthe Spanaki iD, Konstantinos N Fountoulakis

Journal of Clinical Medicine · 23.09.2024 · 13 (18) · 5637

DOI: 10.3390/jcm13185637 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.09.2024. Verfasst von Evangelia Maria Tsapakis und 6 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Psychiatry, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schizophrenia is a chronic psychotic disorder comprising positive symptoms, negative symptoms, and cognitive deficits. Negative symptoms are associated with stigma, worse functional outcomes, and a significant deterioration in quality of life. Clinical diagnosis is challenging despite its significance, and current treatments offer little improvement in the burden of negative symptoms. This article reviews current pharmacological strategies for treating negative symptoms. Dopaminergic, glutamatergic, serotonergic, noradrenergic, cholinergic, anti-inflammatory compounds, hormones, and psychostimulants are explored. Finally, we review pharmacological global treatment guidelines for negative symptoms. In general, switching to a second-generation antipsychotic seems to be most often recommended for patients with schizophrenia on first-generation antipsychotics, and an add-on antidepressant is considered when depression is also present. However, the treatment of negative symptoms remains an unmet need. Future, larger clinical studies and meta-analyses are needed to establish effective pharmacological agents for the effective treatment of negative symptoms.

Schlagwörter

Stichwörter der Autor:innen

negative symptomspharmacological treatmentschizophrenia

Autor:innen und Institutionen

  • 3rd Department of Psychiatry, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • Department of Neurosciences, School of Medicine, University of Crete, 71003 Heraklion, Greece.
  • Department of Psychiatry and Psychotherapy, Medical University of Vienna, 1090 Vienna, Austria.
  • Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Neurology, Agios Pavlos General Hospital of Thessaloniki, 55134 Thessaloniki, Greece.
  • Department of Neurology, University Hospital of Heraklion, Voutes, 71110 Crete, Greece.

ORCID-Profile: Evangelia Maria Tsapakis, Calypso Mitkani, Cleanthe Spanaki

Zitieren

APA

Tsapakis, E. M., Treiber, M., Mitkani, C., Drakaki, Z., Cholevas, A., Spanaki, C., & Fountoulakis, K. N. (2024). Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update. Journal of Clinical Medicine, 13(18), 5637. https://doi.org/10.3390/jcm13185637

Vancouver

Tsapakis EM, Treiber M, Mitkani C, Drakaki Z, Cholevas A, Spanaki C, et al. Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update. Journal of Clinical Medicine. 2024;13(18):5637. doi:10.3390/jcm13185637

BibTeX
@article{Tsapakis2024,
  author = {Tsapakis, Evangelia Maria and Treiber, Michael and Mitkani, Calypso and Drakaki, Zoe and Cholevas, Anastasios and Spanaki, Cleanthe and Fountoulakis, Konstantinos N},
  title = {Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {18},
  pages = {5637},
  doi = {10.3390/jcm13185637}
}
Kostenlos starten →